EUVIMEDEUVIMED entdecken
Crossref

Investigational New Drug Enabling Nonclinical Study of Xenogeneic Life‐Supporting Porcine Kidneys With 10 Gene Edits (10 GE) in a Nonhuman Primate Test System

Daniel L Eisenson iD, Alexander C Schulick iD, WeiLi Chen, Michelle R Santillan iD, Michael Cole, Yu Hisadome, Kasra Shirini iD, Du Gu, Vina Nguyen, Yusuf Ciftci iD, Alice Zhao, Armaan Akbar und 29 weitere

Xenotransplantation · 2026-01 · 33 (1)

DOI: 10.1111/xen.70113 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Xenotransplantation, online erschienen am 23.02.2026. Verfasst von Daniel L Eisenson und 40 weiteren Autor:innen. Beteiligte Einrichtung: Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Transplantation, Heterologous, Kidney Transplantation, Drugs, Investigational. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: United Therapeutics Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This Investigational New Drug (IND) enabling study evaluated life‐supporting kidney xenotransplantation using porcine source animals with 10 gene edits (10 GE) in a nonhuman primate (NHP) test system. Twelve baboons received xenografts with either calcineurin inhibitor (CNI)‐based or CD40/154 costimulation blockade immunosuppression. Source‐specific screening prevented early xenograft antibody‐mediated rejection in recipients, and clinically relevant preservation with hypothermic machine perfusion‐maintained xenograft viability after off‐site procurement at a high health herd facility. No zoonotic infections were detected. Six of 12 recipients achieved survival >3 months without evidence of cell‐ or antibody‐mediated rejection. CNI‐based regimens were well‐tolerated and achieved the longest survivals to date using this approach, contingent on maintenance of therapeutic drug levels. However, xenograft loss among recipients of each immunosuppression regimen was associated with complement activation and microangiopathy, despite 10 GE Xenokidney expression of h CD46 and h CD55 . Complement activation, potentially worsened by infection‐related inflammation, may lead to long‐term 10 GE Xenokidney failure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousKidney TransplantationDrugs, InvestigationalAnimalsSwineImmunosuppressive AgentsHeterograftsPapioGraft RejectionHumansGraft SurvivalKidneyCalcineurin InhibitorsMembrane Cofactor Protein

Substanzen

Immunosuppressive AgentsDrugs, InvestigationalCalcineurin InhibitorsMembrane Cofactor Protein

Autor:innen und Institutionen

  • Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • United Therapeutics Corporation, Silver Spring, Maryland, USA.
  • Experimental Pathology Laboratories, Inc., Sterling, Virginia, USA.
  • University of Minnesota-Veterinary Diagnostic Laboratory, St. Paul, Minnesota, USA.
  • NorthEast BioAnalytical Laboratories LLC, Hamden, Connecticut, USA.

ORCID-Profile: Daniel L Eisenson, Alexander C Schulick, Michelle R Santillan, Kasra Shirini, Yusuf Ciftci, Lars Burdorf, Robert Brodsky, Kazuhiko Yamada

Förderung

  • United Therapeutics Corporation

Zitieren

APA

Eisenson, D. L., Schulick, A. C., Chen, W., Santillan, M. R., Cole, M., Hisadome, Y., Shirini, K., Gu, D., Nguyen, V., Ciftci, Y., Zhao, A., Akbar, A., Babadi, S., Maxwell, A., DeSmet, K., Lorber, M., Peterson, L., Burdorf, L., Kuravi, K., …, & Yamada, K. (2026). Investigational New Drug Enabling Nonclinical Study of Xenogeneic Life‐Supporting Porcine Kidneys With 10 Gene Edits (10 GE) in a Nonhuman Primate Test System. Xenotransplantation, 33(1). https://doi.org/10.1111/xen.70113

Vancouver

Eisenson DL, Schulick AC, Chen W, Santillan MR, Cole M, Hisadome Y, et al. Investigational New Drug Enabling Nonclinical Study of Xenogeneic Life‐Supporting Porcine Kidneys With 10 Gene Edits (10 GE) in a Nonhuman Primate Test System. Xenotransplantation. 2026;33(1). doi:10.1111/xen.70113

BibTeX
@article{Eisenson2026,
  author = {Eisenson, Daniel L and Schulick, Alexander C and Chen, WeiLi and Santillan, Michelle R and Cole, Michael and Hisadome, Yu and Shirini, Kasra and Gu, Du and Nguyen, Vina and Ciftci, Yusuf and Zhao, Alice and Akbar, Armaan and Babadi, Saghar and Maxwell, Amanda and DeSmet, Kristina and Lorber, Marc and Peterson, Leigh and Burdorf, Lars and Kuravi, Kasinath and Rahman, Farzana and Sorrells, Lori and Kokkinaki, Maria and Warren, Daniel and King, Betsy and Wesson, Russell and Rabb, Hamid and Jones, June and Funk, Kathleen and Sturos, Matthew and Puttabyatappa, Muraly and Verma, Brijesh and Avery, Robin and Johnson, Thomas and Clarke, William and Brodsky, Robert and Bettinotti, Maria and Rosenberg, Avi and Iwase, Hayato and Ayares, David and Cameron, Andrew and Yamada, Kazuhiko},
  title = {Investigational New Drug Enabling Nonclinical Study of Xenogeneic Life‐Supporting Porcine Kidneys With 10 Gene Edits (10 GE) in a Nonhuman Primate Test System},
  journal = {Xenotransplantation},
  year = {2026},
  volume = {33},
  number = {1},
  doi = {10.1111/xen.70113}
}
Kostenlos starten →